Archives of Psychiatry and Mental Health

AcademicKeys
Publons
Google Scholar
Google Scholar

Contact Information

Heighten Science Publications Corporation

+4043820291
hjcap@heighpubs.us
info@heighpubs.us
2504 Stillwater CT, Flower Mound
Texas - 75022, USA

Send us a Mail

We've received your message.
Thank you!
Articles Journals Editors Reviewers
Heighpubs » hjcap » articles

Volume 1 Issue 1

  • article icon
    Research Article
    Published: 10/18/2017 | Pages: 1(1): 001-010

    Comparison of Cardiovascular Risks following Smoking Cessation Treatments Using Varenicline vs. NRT among Schizophrenic Smokers

    I-Hsuan Wu, Hua Chen, Patrick Bordnick, Ekere James Essien, Michael Johnson, Ronald J Peters and Susan Abughosh*

    Background: Schizophrenic patients have a lot higher smoking rates when compared to people in the general population. A variety of pharmaceutical cessation aids are available, which include nicotine replacement therapy (NRT), Bupropion SR, and Varenicline. Our objective was to assess which cessation medication would have lower risks in developing risk factors of cardiovascular diseases.

    PDF   HTML